Inhibition of human sulfotransferases (SULTs) by per- and polyfluoroalkyl substances (PFASs) and structure-activity relationship.

[1]  S. Pramanik,et al.  In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS) , 2022, Archives of Toxicology.

[2]  K. Kannan,et al.  First Evidence of Prenatal Exposure to Emerging Poly- and Perfluoroalkyl Substances Associated with E-Waste Dismantling: Chemical Structure-Based Placental Transfer and Health Risks. , 2022, Environmental science & technology.

[3]  F. Deng,et al.  Emerging and Legacy Per- and Polyfluoroalkyl Substances in an Elderly Population in Jinan, China: The Exposure Level, Short-Term Variation, and Intake Assessment. , 2022, Environmental science & technology.

[4]  Hui-Sheng Huang,et al.  Inhibition of Human Sulfotransferases by Phthalate Monoesters , 2022, Frontiers in Endocrinology.

[5]  Qianlong Zhang,et al.  Environmental exposure to legacy poly/perfluoroalkyl substances, emerging alternatives and isomers and semen quality in men: A mixture analysis. , 2022, The Science of the total environment.

[6]  Changtao Jiang,et al.  Inhibition of hydroxylated polychlorinated biphenyls (OH-PCBs) on sulfotransferases (SULTs). , 2021, Environmental pollution.

[7]  M. Petriello,et al.  Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury. , 2021, Environment international.

[8]  K. Kannan,et al.  Legacy and Emerging Poly- and Perfluoroalkyl Substances in Finless Porpoises from East China Sea: Temporal Trends and Tissue-Specific Accumulation. , 2021, Environmental science & technology.

[9]  K. Steenland,et al.  PFAS and cancer, a scoping review of the epidemiologic evidence. , 2020, Environmental research.

[10]  B. Brooks,et al.  8:8 Perfluoroalkyl phosphinic acid affects neurobehavioral development, thyroid disruption, and DNA methylation in developing zebrafish. , 2020, The Science of the total environment.

[11]  A. Pradhan,et al.  Perfluorinated alkyl substances impede growth, reproduction, lipid metabolism and lifespan in Daphnia magna. , 2020, The Science of the total environment.

[12]  Z. Fang,et al.  Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases. , 2020, Environmental pollution.

[13]  T. Fletcher,et al.  Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water , 2020, Environmental Health.

[14]  M. Verma,et al.  Drug-metabolizing enzymes: role in drug resistance in cancer , 2020, Clinical and Translational Oncology.

[15]  Z. Fang,et al.  Per- and polyfluoroalkyl substances display structure-dependent inhibition towards UDP-glucuronosyltransferases. , 2019, Environmental pollution.

[16]  J. Rüegg,et al.  Environmental chemicals differentially affect epigenetic-related mechanisms in the zebrafish liver (ZF-L) cell line and in zebrafish embryos. , 2019, Aquatic toxicology.

[17]  Haiyan Jing,et al.  SULT1E1 inhibits cell proliferation and invasion by activating PPARγ in breast cancer , 2018, Journal of Cancer.

[18]  G. Kissling,et al.  Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague–Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days , 2018, Journal of immunotoxicology.

[19]  E. Fliers,et al.  The classic pathways of thyroid hormone metabolism , 2017, Molecular and Cellular Endocrinology.

[20]  A. Calafat,et al.  Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community. , 2017, Environment international.

[21]  G. Jiang,et al.  Structure-Dependent Hematological Effects of Per- and Polyfluoroalkyl Substances on Activation of Plasma Kallikrein-Kinin System Cascade. , 2017, Environmental science & technology.

[22]  K. Vouk,et al.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer , 2017, Front. Pharmacol..

[23]  R. Zeillinger,et al.  Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer , 2017, Oncology letters.

[24]  R. Venkataramanan,et al.  Drug Metabolism in the Liver. , 2017, Clinics in liver disease.

[25]  A. Ekblad,et al.  Comparison of PFASs contamination in the freshwater and terrestrial environments by analysis of eggs from osprey (Pandion haliaetus), tawny owl (Strix aluco), and common kestrel (Falco tinnunculus). , 2016, Environmental research.

[26]  Y. Saeki,et al.  Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. , 2015, Journal of biochemistry.

[27]  P. Foster,et al.  The Regulation of Steroid Action by Sulfation and Desulfation , 2015, Endocrine reviews.

[28]  J. Li,et al.  Association of polyfluoroalkyl chemical exposure with serum lipids in children. , 2015, The Science of the total environment.

[29]  R. Kishi,et al.  The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study , 2015, Environmental health perspectives.

[30]  Yali Shi,et al.  Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun lake, china. , 2014, Environmental science & technology.

[31]  A. Gasbarrini,et al.  A case–control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease , 2014, Genes & Nutrition.

[32]  M. James,et al.  Interactions of cytosolic sulfotransferases with xenobiotics , 2013, Drug metabolism reviews.

[33]  Konrad Hungerbühler,et al.  Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. , 2013, Environment international.

[34]  Z. Lu,et al.  Downregulation of Sulfotransferase Expression and Activity in Diseased Human Livers , 2013, Drug Metabolism and Disposition.

[35]  Heqing Shen,et al.  Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells. , 2012, Toxicology.

[36]  J. Morrow,et al.  SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies. , 2012, Molecular pharmaceutics.

[37]  Q. Lian,et al.  Perfluorinated chemicals in blood of residents in Wenzhou, China. , 2011, Ecotoxicology and environmental safety.

[38]  James Franklin,et al.  Perfluoroalkyl and Polyfluoroalkyl Substances in the Environment: Terminology, Classification, and Origins , 2011, Integrated environmental assessment and management.

[39]  M. Meyer,et al.  In vitro approaches to studying the metabolism of new psychoactive compounds. , 2011, Drug testing and analysis.

[40]  T. Zhou,et al.  Sulfation of dietary flavonoids by human sulfotransferases , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[41]  A. A. Jensen,et al.  Do Perfluoroalkyl Compounds Impair Human Semen Quality? , 2009, Environmental health perspectives.

[42]  J. Pasqualini.  Estrogen Sulfotransferases in Breast and Endometrial Cancers , 2009, Annals of the New York Academy of Sciences.

[43]  Shufeng Zhou,et al.  Structure, function and polymorphism of human cytosolic sulfotransferases. , 2008, Current drug metabolism.

[44]  Timothy J Wallington,et al.  Atmospheric chemistry of N-methyl perfluorobutane sulfonamidoethanol, C4F9SO2N(CH3)CH2CH2OH: kinetics and mechanism of reaction with OH. , 2006, Environmental science & technology.

[45]  T J Wallington,et al.  Atmospheric chemistry of perfluoroalkanesulfonamides: kinetic and product studies of the OH radical and Cl atom initiated oxidation of N-ethyl perfluorobutanesulfonamide. , 2006, Environmental science & technology.

[46]  M. James,et al.  Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  G. Pacifici.  Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. , 2004, International journal of clinical pharmacology and therapeutics.

[48]  Kiyomi Ito,et al.  Database analyses for the prediction of in vivo drug-drug interactions from in vitro data. , 2004, British journal of clinical pharmacology.

[49]  F. Kauffman,et al.  Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[50]  M. Coughtrie,et al.  A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. , 1998, Molecular pharmacology.

[51]  C. Klaassen,et al.  The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  E. Testai,et al.  Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy. , 2018, Environment international.

[53]  C. Falany,et al.  Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4 , 2017, Hormone molecular biology and clinical investigation.

[54]  Bert van Bavel,et al.  Biotransformation of fluorotelomer compound to perfluorocarboxylates in humans. , 2013, Environment international.

[55]  M. James,et al.  Inhibition of sulfotransferases by xenobiotics. , 2006, Current drug metabolism.

[56]  S. Sheweita.  Drug-metabolizing enzymes: mechanisms and functions. , 2000, Current drug metabolism.